Skip to main content
. 2013 Jul 17;36(Suppl 2):S127–S138. doi: 10.2337/dcS13-2011

Figure 6.

Figure 6

Durability of glycemic control with TZDs. Summary of studies examining the effect of TZDs versus placebo or versus active comparator on HbA1c in T2DM subjects. See text for a more detailed discussion (70,82,8792). Pio, pioglitazone; Rosi, rosiglitazone.